Where medals and medallions are forged

Whether you like your scientists to be medallion wearers or medal winners or indeed both is I suppose a matter of personal preference.  In one of those strange juxtapositions in life I chanced across news of this month's US GQ feature (no, I don't read it) on 'Rock Stars of Science' shortly before leaving my office … Continue reading Where medals and medallions are forged

The Public health white paper – a new school of thought

'Healthy Lives, Healthy People,' the White Paper on public health has been published and is available on the Department of Health website. The news release sets out the Secretary of State's 'ladder of intervention' - from the rather refreshingly titled  'do nothing' up to 'eliminate choice altogether' - which sound like the different states of readiness one … Continue reading The Public health white paper – a new school of thought

Up a ladder with the public health white paper

If you refuse to walk under, or indeed climb, ladders then this blog is not for you. The public health white paper is to be launched tomorrow (Tuesday).  There has been much trailing of various proposals that will likely appear in the document - from providing vouchers to school children who walk to school, to a … Continue reading Up a ladder with the public health white paper

Earl Howe's Speech at the AMRC AGM

 I thought you may be interested in this extract from the Health Minister, Earl Howe's, speech to out AGM on Wednesday: It also gives me pleasure to note [that] AMRC member expenditure on research having exceeded £1 billion for the year for the first time. Given the economic circumstances, I think this is something about which … Continue reading Earl Howe's Speech at the AMRC AGM

When good medicine is the casualty of hype and ignorance

I have just returned from the Financial Times' offices, where I was the guest for their regular science podcast hosted by Clive Cookson and Andrew Jack (it will appear here later today).  The theme of the discussion was 'Selling Sickness.'  Andrew was reporting on a recent conference of the same name that took place last month in Holland.  … Continue reading When good medicine is the casualty of hype and ignorance

Public, private and charitable research: the spillover effect

RAND Europe and the Office of Health Economics (OHE) last week published this rather fascinating occasional paper from a seminar in May.  It examines the spillovers (wider benefits) from biomedical and health research and seems highly salient given what is going on.  I thought some of the diagrams were helpful in visualising the multilying effect of … Continue reading Public, private and charitable research: the spillover effect